Senior machine learning scientist
2 days ago
toronto, ontario, Canada
Altis Labs
Full-time
Free with email or Google
Save this job and keep your search organized
Create a free account to save jobs, create alerts and return to this listing from your dashboard.
Free with email or Google
By continuing, you agree to our Terms & Privacy Policy.
What We Do We build AI models to enable smaller, faster, and more successful clinical trials.
What We Do We build AI models to enable smaller, faster, and more successful clinical trials.
About Altis Labs Altis Labs is a computational imaging company focused on improving how oncology trials measure treatment benefit. Our core technology is IPRO, an AI model that generates patient-level outcome predictions directly from routine medical imaging data. Our global biopharma customers use IPRO to predict efficacy, navigate billion-dollar development decisions with confidence, and move their most promising therapies through Phase I–III trials faster. IPRO is trained on the industry’s largest real-world imaging, clinical, and outcomes database, containing over 210 million longitudinal images and more than one million patient-years of linked outcomes.
Our multidisciplinary team of AI scientists, clinicians, and business operators is on a mission to get the most effective treatments to patients sooner. We collaborate closely with academic medical centers and co-publish our results at top-tier medical conferences.
Altis is headquartered in Toronto, serves 6 of the top 20 global biopharmaceutical companies, and is backed by leading life sciences and technology investors.
What Makes This Role Compelling Unusually rich data: Access to large, diverse patient datasets with longitudinal outcomes across multiple cancer types
Novel methodology: We're developing approaches that push beyond standard practices in medical imaging AI
Multi-cancer generalization: Building methods that
What We Do We build AI models to enable smaller, faster, and more successful clinical trials.
About Altis Labs Altis Labs is a computational imaging company focused on improving how oncology trials measure treatment benefit. Our core technology is IPRO, an AI model that generates patient-level outcome predictions directly from routine medical imaging data. Our global biopharma customers use IPRO to predict efficacy, navigate billion-dollar development decisions with confidence, and move their most promising therapies through Phase I–III trials faster. IPRO is trained on the industry’s largest real-world imaging, clinical, and outcomes database, containing over 210 million longitudinal images and more than one million patient-years of linked outcomes.
Our multidisciplinary team of AI scientists, clinicians, and business operators is on a mission to get the most effective treatments to patients sooner. We collaborate closely with academic medical centers and co-publish our results at top-tier medical conferences.
Altis is headquartered in Toronto, serves 6 of the top 20 global biopharmaceutical companies, and is backed by leading life sciences and technology investors.
What Makes This Role Compelling Unusually rich data: Access to large, diverse patient datasets with longitudinal outcomes across multiple cancer types
Novel methodology: We're developing approaches that push beyond standard practices in medical imaging AI
Multi-cancer generalization: Building methods that